DrugCite
Search

INFERGEN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Infergen Adverse Events Reported to the FDA Over Time

How are Infergen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Infergen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Infergen is flagged as the suspect drug causing the adverse event.

Most Common Infergen Adverse Events Reported to the FDA

What are the most common Infergen adverse events reported to the FDA?

Fatigue
111 (2.93%)
Nausea
79 (2.08%)
Anaemia
77 (2.03%)
Asthenia
67 (1.77%)
White Blood Cell Count Decreased
67 (1.77%)
Weight Decreased
57 (1.5%)
Depression
49 (1.29%)
Headache
47 (1.24%)
Platelet Count Decreased
47 (1.24%)
Pyrexia
45 (1.19%)
Pain
43 (1.13%)
Show More Show More
Vomiting
43 (1.13%)
Dizziness
42 (1.11%)
Haemoglobin Decreased
42 (1.11%)
Insomnia
41 (1.08%)
Decreased Appetite
38 (1%)
Blood Glucose Increased
36 (.95%)
Dyspnoea
36 (.95%)
Red Blood Cell Count Decreased
36 (.95%)
Aspartate Aminotransferase Increase...
30 (.79%)
Haematocrit Decreased
30 (.79%)
Neutropenia
30 (.79%)
Arthralgia
28 (.74%)
Influenza Like Illness
28 (.74%)
Dehydration
27 (.71%)
Alanine Aminotransferase Increased
26 (.69%)
Chills
26 (.69%)
Chest Pain
25 (.66%)
Condition Aggravated
22 (.58%)
Diarrhoea
22 (.58%)
Feeling Abnormal
22 (.58%)
Abdominal Pain
21 (.55%)
Amnesia
21 (.55%)
Back Pain
21 (.55%)
Confusional State
19 (.5%)
Constipation
19 (.5%)
Drug Ineffective
19 (.5%)
Leukopenia
19 (.5%)
Anxiety
18 (.47%)
Injection Site Pain
18 (.47%)
Myalgia
18 (.47%)
Pneumonia
18 (.47%)
Anorexia
16 (.42%)
Blood Potassium Decreased
16 (.42%)
Cellulitis
16 (.42%)
Alopecia
15 (.4%)
Fall
15 (.4%)
Loss Of Consciousness
15 (.4%)
Malaise
15 (.4%)
Memory Impairment
15 (.4%)
Muscle Spasms
15 (.4%)
No Therapeutic Response
15 (.4%)
Pain In Extremity
15 (.4%)
Thrombocytopenia
15 (.4%)
Treatment Noncompliance
15 (.4%)
Tremor
15 (.4%)
Disturbance In Attention
14 (.37%)
Balance Disorder
13 (.34%)
Cough
13 (.34%)
Paraesthesia
13 (.34%)
Abdominal Pain Upper
12 (.32%)
Agitation
12 (.32%)
Blood Calcium Decreased
12 (.32%)
Blood Pressure Increased
12 (.32%)
Convulsion
12 (.32%)
Haemolytic Anaemia
12 (.32%)
Hyperhidrosis
12 (.32%)
Incorrect Dose Administered
11 (.29%)
Injection Site Erythema
11 (.29%)
Rash
11 (.29%)
Treatment Failure
11 (.29%)
Wrong Technique In Drug Usage Proce...
11 (.29%)
Abasia
10 (.26%)
Hypotension
10 (.26%)
Neutrophil Count Decreased
10 (.26%)
Oedema Peripheral
10 (.26%)
Pulmonary Embolism
10 (.26%)
Renal Failure Acute
10 (.26%)
Somnolence
10 (.26%)
Cerebrovascular Accident
9 (.24%)
Erythema
9 (.24%)
Hypoaesthesia
9 (.24%)
Hypokalaemia
9 (.24%)
Red Cell Distribution Width Increas...
9 (.24%)
Syncope
9 (.24%)
Transient Ischaemic Attack
9 (.24%)
Viral Load Increased
9 (.24%)
Activities Of Daily Living Impaired
8 (.21%)
Ammonia Increased
8 (.21%)
Blood Bilirubin Increased
8 (.21%)
Blood Creatinine Increased
8 (.21%)
Blood Uric Acid Increased
8 (.21%)
Disorientation
8 (.21%)
Dry Mouth
8 (.21%)
Dry Skin
8 (.21%)
Gait Disturbance
8 (.21%)
Hepatitis C
8 (.21%)
Hypersomnia
8 (.21%)
Hyperuricaemia
8 (.21%)
Hypophagia
8 (.21%)
Hypothyroidism
8 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Infergen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Infergen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Infergen

What are the most common Infergen adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Infergen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Infergen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Infergen According to Those Reporting Adverse Events

Why are people taking Infergen, according to those reporting adverse events to the FDA?

Hepatitis C
464
Product Used For Unknown Indication
16
Drug Use For Unknown Indication
12
Hepatitis C Virus
9
Hepatitis C Virus Test
3
Multiple Myeloma
2
Show More Show More
Hepatitis
2
Chronic Hepatitis
1
Metastatic Renal Cell Carcinoma
1

Drug Labels

LabelLabelerEffective
InfergenKadmon Pharmaceuticals, LLC07-JAN-13

Infergen Case Reports

What Infergen safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Infergen. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Infergen.